Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A randomised, double-blind, placebo- and active-comparator controlled, 4-arm, parallel-group, 26 week multicentre study with a 26 week extension, to evaluate the efficacy, safety, and tolerability of JNJ-28431754 (Canagliflozin) versus placebo and sitagliptin in the treatment of subjects with type 2 diabetes mellitus with inadequate glycaemic control on metformin and sulphonylurea therapy

Next Previous
X
Search
Trial Profile

A randomised, double-blind, placebo- and active-comparator controlled, 4-arm, parallel-group, 26 week multicentre study with a 26 week extension, to evaluate the efficacy, safety, and tolerability of JNJ-28431754 (Canagliflozin) versus placebo and sitagliptin in the treatment of subjects with type 2 diabetes mellitus with inadequate glycaemic control on metformin and sulphonylurea therapy

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 16 Jun 2016

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Canagliflozin (Primary) ; Sitagliptin
  • Indications Type 2 diabetes mellitus
  • Focus Adverse reactions; Therapeutic Use

    • Most Recent Events

    • 17 Jun 2013 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
    • 22 Nov 2010 Status changed from not yet recruiting to recruiting.
    • 08 Sep 2010 New trial record

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top